Search

Home > GRACEcast Lung Cancer Video > Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive Non-small Cell Lung Cancer?
Podcast: GRACEcast Lung Cancer Video
Episode:

Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive Non-small Cell Lung Cancer?
Category: Science & Medicine
Duration: 00:01:43
Publish Date: 2014-05-15 14:00:00
Description:

Dr. Joel Neal of Stanford University Medical Center discusses the SELECT clinical trial which studied early stage non-small cell lung cancer patients and whether or not Tarceva (erlotinib) would prevent disease recurrence. February 2014.
Total Play: 0